Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5AP | P20292 | 19/20 | 0.47 |
| ▸ | FEN1 | P39748 | 18/20 | 0.47 |
| ▸ | ACLY | P53396 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7130070 | 0.83 | ALOX5AP (0.55) | ALOX5APFEN1 | |
| SCHEMBL7237315 | 0.80 | ALOX5AP (0.53) | ALOX5APFEN1 | |
| SCHEMBL9118640 | 0.80 | ALOX5AP (0.58) | ALOX5APFEN1 | |
| SCHEMBL2280981 | 0.76 | ALOX5AP (0.54) | ALOX5APFEN1 | |
| SCHEMBL890690 | 0.76 | ALOX5AP (0.54) | ALOX5APFEN1 | |
| SCHEMBL15916565 | 0.75 | ALOX5AP (0.60) | ALOX5APFEN1 | |
| SCHEMBL15936747 | 0.74 | ALOX5AP (0.62) | ALOX5APFEN1 | |
| SCHEMBL7128878 | 0.74 | ALOX5AP (0.53) | ALOX5APFEN1 | |
| SCHEMBL1968159 | 0.73 | ALOX5AP (0.59) | ALOX5APFEN1 | |
| SCHEMBL7995533 | 0.73 | ALOX5AP (0.49) | ALOX5APFEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030114448-A1 | Inhibitors of factor Xa | MILLENNIUM PHARMACEUTICALS, INC. | 2003-06-19 | — | — | US | disclosed |
| WO-2002096873-A1 | ISOINDOLE AND ISOQUINOLINE DERIVATIVES AS INHIBITORS OF FACTOR XA | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2002-12-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030114448-A1 | Inhibitors of factor Xa | SERPINC1, F11, TFPI | ALOX5AP 415/4885FEN1 1574/4885ACLY 1491/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.